Fas (CD95, APO-1, TNFRSF6) is a TNF receptor superfamily member that directly triggers apoptosis and contributes to the maintenance of lymphocyte homeostasis and prevention of autoimmunity. Although FADD and caspase-8 have been identified as key intracellular mediators of Fas signaling, it is not clear how recruitment of these proteins to the Fas death domain leads to activation of caspase-8 in the receptor signaling complex. We have used high-resolution confocal microscopy and live cell imaging to study the sequelae of early events in Fas signaling. These studies have revealed a new stage of Fas signaling in which receptor ligation leads to the formation of surface receptor oligomers that we term signaling protein oligomerization transduction structures (SPOTS). Formation of SPOTS depends on the presence of an intact Fas death domain and FADD but is independent of caspase activity. Analysis of cells expressing Fas mutations from patients with the autoimmune lymphoproliferative syndrome (ALPS) reveals that formation of SPOTS can be disrupted by distinct mechanisms in ALPS.
Skip Nav Destination
Article navigation
22 November 2004
Article Contents
Article|
November 22 2004
SPOTS : signaling protein oligomeric transduction structures are early mediators of death receptor–induced apoptosis at the plasma membrane
Richard M. Siegel,
Richard M. Siegel
1Laboratory of Immunology, National Institute of Allergy and Infectious Diseases
3Immunoregulation Unit, Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MA 20892
Search for other works by this author on:
Jagan R. Muppidi,
Jagan R. Muppidi
3Immunoregulation Unit, Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MA 20892
Search for other works by this author on:
Malabika Sarker,
Malabika Sarker
1Laboratory of Immunology, National Institute of Allergy and Infectious Diseases
Search for other works by this author on:
Adrian Lobito,
Adrian Lobito
3Immunoregulation Unit, Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MA 20892
Search for other works by this author on:
Melinda Jen,
Melinda Jen
1Laboratory of Immunology, National Institute of Allergy and Infectious Diseases
Search for other works by this author on:
David Martin,
David Martin
1Laboratory of Immunology, National Institute of Allergy and Infectious Diseases
Search for other works by this author on:
Stephen E. Straus,
Stephen E. Straus
2Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases
Search for other works by this author on:
Michael J. Lenardo
Michael J. Lenardo
1Laboratory of Immunology, National Institute of Allergy and Infectious Diseases
Search for other works by this author on:
Richard M. Siegel
1Laboratory of Immunology, National Institute of Allergy and Infectious Diseases
3Immunoregulation Unit, Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MA 20892
Jagan R. Muppidi
3Immunoregulation Unit, Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MA 20892
Malabika Sarker
1Laboratory of Immunology, National Institute of Allergy and Infectious Diseases
Adrian Lobito
3Immunoregulation Unit, Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MA 20892
Melinda Jen
1Laboratory of Immunology, National Institute of Allergy and Infectious Diseases
David Martin
1Laboratory of Immunology, National Institute of Allergy and Infectious Diseases
Stephen E. Straus
2Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases
Michael J. Lenardo
1Laboratory of Immunology, National Institute of Allergy and Infectious Diseases
Correspondence to Richard M. Siegel: [email protected]
D. Martin's present address is Dept. of Medicine, University of Washington School of Medicine, Seattle, WA 98195.
Abbreviations used in this paper: ALPS, autoimmune lymphoproliferative syndrome; DD, death domain; DISC, death-inducing signaling complex; FasL, Fas ligand; SPOTS, signaling protein oligomerization transduction structures.
Received:
June 16 2004
Accepted:
September 17 2004
Online ISSN: 1540-8140
Print ISSN: 0021-9525
2004
J Cell Biol (2004) 167 (4): 735–744.
Article history
Received:
June 16 2004
Accepted:
September 17 2004
Citation
Richard M. Siegel, Jagan R. Muppidi, Malabika Sarker, Adrian Lobito, Melinda Jen, David Martin, Stephen E. Straus, Michael J. Lenardo; SPOTS : signaling protein oligomeric transduction structures are early mediators of death receptor–induced apoptosis at the plasma membrane . J Cell Biol 22 November 2004; 167 (4): 735–744. doi: https://doi.org/10.1083/jcb.200406101
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
